M&A - SS Innovations International, Inc.
Form Type: 10-K
Filing Date: 2025-04-15
Corporate Action: Acquisition
Type: Update
Accession Number: 000121390025031773
Filing Summary: SS Innovations International, Inc. (SSi) focused on advancing surgical robotics technology with its SSi Mantra system aimed at democratizing access to surgical robotics. Major developments in 2024 included the regulatory approval of the SSi Mantra in multiple countries and significant achievements in robotic surgical procedures, with over 3,500 surgeries completed. The company underwent a pivotal merger with CardioVentures, significantly altering its ownership structure. This merger facilitated the integration of advanced surgical robotic capabilities aimed at expanding global market reach. The strategic direction includes active discussions with regulatory bodies for further approvals to enhance their product offerings in underserved markets.
Additional details:
Company Background: SS Innovations International, Inc. is a commercial-stage surgical robotics company focusing on advanced surgical technologies.
Product Name: SSi Mantra
Installed Systems Count: 62
Surgical Procedures Count: 3750
Regulatory Approval Countries: India, Guatemala, Nepal, Ecuador, Indonesia
Recent Surgical Milestones: First pyeloplasty on an infant in April 2024; over 100 robotic cardiac surgeries completed by May 2024.
Acquisition Details: On April 14, 2023, SSi acquired CardioVentures, altering the company structure and ownership.
Shares Outstanding: 193,559,340 shares as of April 14, 2025.
Market Value: $138,432,760.
Comments
No comments yet. Be the first to comment!